<div id="readability-page-1">03:00 PM EST, 11/13/2025 (MT Newswires) -- WW International ( WW ) plans to offer Novo Nordisk's ( NVO ) Wegovy in pill form if it is launched in the US next year, Reuters reported Wednesday, citing WW CEO Tara Comonte.&#34;We have been working with Novo Nordisk ( NVO ) ahead of time to support the launch of oral weight-loss medication,&#34; Comonte was quoted as saying in an interview.&#34;A lot of people don't want an injection. And the convenience of a pill is going to be huge,&#34; she said.WW did not immediately respond to a request for comment from MT Newswires.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)Price: 27.88, Change: +0.09, Percent Change: +0.34 MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</div>

WW International 計劃在明年如果在美國推出 Novo Nordisk 的 Wegovy 時提供藥丸形式。首席執行官 Tara Comonte 強調了藥丸相較於注射的便利性。WW 一直在與 Novo Nordisk 合作，以支持這一口服減肥藥物的推出。WW 未對 MT Newswires 的評論請求作出回應

市場傳聞：WW 計劃在 Wegovy 藥丸推出後提供該產品